Novavax earnings expectations
WebOct 28, 2024 · Zacks Consensus Estimate This vaccine maker is expected to post quarterly loss of $4.04 per share in its upcoming report, which represents a year-over-year change of -25.9%. Revenues are expected... WebMay 10, 2024 · The company reiterated its expectation for $4 billion to $5 billion in full-year revenue. The midpoint of the outlook is in line with NVAX stock analyst estimates for …
Novavax earnings expectations
Did you know?
WebJul 28, 2024 · We expect investors to focus on the sales performance of Novavax’s NVAX protein-based COVID-19 vaccine, its sole marketed product, when it r... WebJul 28, 2024 · NVAX’s surprise record has been dismal so far, as its earnings missed expectations in each of the last four quarters. It has a trailing four-quarter negative …
WebMay 3, 2024 · We expect Novavax, Inc. NVAX to beat expectations when it reports first-quarter 2024 results on May 9, after the market closes.NVAX’s surprise record has been dismal so far, as its earnings ... WebFeb 28, 2024 · In the three months that ended December, the Gaithersburg, MD.-based company is expected to post a per-share loss of 92 cents on revenue of $383.14 million. This compares to the year-ago quarter...
WebApr 15, 2024 · The consensus estimate for Novavax’s current full-year earnings is ($5.66) per share. ... The company had revenue of $357.40 million for the quarter, compared to analysts’ expectations of $383 ... WebApr 15, 2024 · The consensus estimate for Novavax’s current full-year earnings is ($5.66) per share. ... The company had revenue of $357.40 million during the quarter, compared …
WebMay 10, 2024 · The company reiterated its expectation for $4 billion to $5 billion in full-year revenue. The midpoint of the outlook is in line with NVAX stock analyst estimates for $4.49 billion. Analysts also...
WebApr 9, 2024 · Novavax, Inc. has a 12 month low of $5.61 and a 12 month high of $76.77. Novavax (NASDAQ:NVAX – Get Rating) last announced its earnings results on Tuesday, February 28th. The biopharmaceutical ... rb6 year 8 passWebAug 8, 2024 · Updated Aug. 8, 2024 4:12 pm ET. print. Text. Novavax Inc. slashed its full-year revenue outlook in half on Monday, citing a lack of demand for its Covid-19 vaccine from an international ... sims 2 ikea stuff packWebApr 11, 2024 · The trading price of Novavax Inc. (NASDAQ:NVAX) closed lower on Monday, April 10, closing at $8.00, -5.44% lower than its previous close. ... Inc., whose market valuation is $618.56 million at the time of this writing, is expected to release its quarterly earnings report May 08, 2024 – May 12, 2024. Investors’ optimism about the company’s ... rb6 westbound timetableWebFeb 27, 2024 · Novavax will be reporting earnings from the last quarter on February 28. 5 analysts forecast losses of $1.802 per share as opposed to losses of $2.700 in the same … rb7151 hexagonal optics azulWebApr 15, 2024 · Zacks Research analyst S. Ganoria now forecasts that the biopharmaceutical company will earn $1.95 per share for the year, up from their previous estimate of $1.87. … rb6 year 8WebAug 9, 2024 · In its second-quarter earnings on Monday, Novavax announced sales of just $186 million for the quarter, far below analyst expectations of $1.02 billion, according to FactSet. The Maryland-based ... rb6 year 7WebNovavax, Inc. is expected* to report earnings on 02/28/2024 after market close. The report will be for the fiscal Quarter ending Dec 2024. According to Zacks Investment Research, … rb 70 music